cefotaxime and Communicable-Diseases--Emerging

cefotaxime has been researched along with Communicable-Diseases--Emerging* in 3 studies

Other Studies

3 other study(ies) available for cefotaxime and Communicable-Diseases--Emerging

ArticleYear
Infections by emerging serogroups of Neisseria meningitidis: A case report.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Communicable Diseases, Emerging; Community-Acquired Infections; Disease Notification; Dyspnea; Female; Humans; Incidence; Meningococcal Infections; Neisseria meningitidis; Serotyping; Spain

2019
[Streptococcus suis type 2: emerging pathogen producer of meningitis].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:4

    Topics: Alcoholism; Cefotaxime; Communicable Diseases, Emerging; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Environmental Exposure; Humans; Immunocompromised Host; Male; Meningitis, Bacterial; Middle Aged; Rural Health; Spain; Streptococcal Infections; Streptococcus suis

2012
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.
    The Journal of infectious diseases, 2002, Jul-01, Volume: 186, Issue:1

    Monitoring antibiotic-resistant pneumococcal strains not covered by the 7-valent conjugate vaccine is an important priority. The Centers for Disease Control and Prevention's Active Bacterial Core Surveillance identified 68 invasive penicillin-nonsusceptible serotype 35B (PN35B) isolates recovered from 1995 to 2001 from patients residing in the states of California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New York, Oregon, Tennessee, and Texas. Nonsusceptible isolates accounted for 69% of all serotype 35B isolates recovered during this time. Twelve (18%) of the 68 PN35B isolates recovered since 1995 were obtained from pediatric patients. These 68 isolates exhibited penicillin MICs of 0.25-2 microg/mL and reduced susceptibility to cefotaxime. Representative PN35B isolates exhibited a common chromosomal macrorestriction profile and identical penicillin-binding-protein gene restriction profiles characteristic of penicillin-resistant strains, and they shared a unique 7-locus sequence type that included 3 new alleles. The mosaic pbp2b and divergent ddl sequences were suggestive of interspecies recombination at the ddl-pbp2b chromosomal region.

    Topics: Adolescent; Adult; Alleles; Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Child; Communicable Diseases, Emerging; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Middle Aged; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; United States

2002